NCT05675709
- Conditions
- Cutaneous Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
Clinical trial condition
Cutaneous Melanoma
Explore clinical trials studying Cutaneous Melanoma. Study availability and eligibility vary by location and protocol.
56 public trials
25 recruiting studies
Cutaneous Melanoma trial results
NCT02831634
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
- Locations
-
- Institut Curie Paris, France
NCT05578872
- Conditions
- Adult Disease, Advanced Solid Tumor, Cutaneous Melanoma, +19 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California San Diego La Jolla, California, United States
- University of California San Francisco San Francisco, California, United States
- University of Colorado Denver Denver, Colorado, United States
NCT03761017
- Conditions
- Advanced Cancer, Colonic Diseases, Colorectal Cancer, +24 more
- Locations
-
- University of Chicago Medical Center Chicago, Illinois, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT02791334
- Conditions
- Breast Cancer (HR+HER2-), Breast Diseases, Breast Neoplasms, +22 more
- Locations
-
- Tennessee Oncology PLLC Nashville, Tennessee, United States
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
- The START Center for Cancer Care San Antonio, Texas, United States
- Cliniques Universitaires Saint-Luc Brussels, Belgium
NCT02519322
- Conditions
- Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +25 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
- M D Anderson Cancer Center Houston, Texas, United States
NCT03843593
- Conditions
- Cutaneous Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Westchester (All Protocol Activities) Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Completed
Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma
NCT00679289
- Conditions
- Cutaneous Melanoma, Melanoma, Metastatic Melanoma, +11 more
- Locations
-
- University of Chicago Hospital Chicago, Illinois, United States
- University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
NCT04551352
- Conditions
- Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +16 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Thomas Jefferson University Hospital;Medical Oncology Philadelphia, Pennsylvania, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
Completed
Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine
NCT03633110
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +39 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- John Wayne Cancer Institute - Providence Saint John's Health Center Santa Monica, California, United States
- University of Colorado, Anschutz Cancer Pavilion Aurora, Colorado, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States